A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Hemophilia & Sickle Cell Bookmark and Share

Hemophilia and Sickle Cell Program

The Hemophilia and Sickle Cell Program at City of Hope provides care to children, adolescents and young adults (AYA) with inherited coagulation disorders, such as hemophilia and red blood cell disorders like sickle cell anemia. We are a regional referral center for these disorders and provide support to hospitals and physicians locally, nationally and internationally.

Our hemophilia and sickle cell program has earned Center of Excellence designations from California Children’s Services, and we are one of approximately 145 federally funded comprehensive Hemophilia Treatment Centers (HTCs) in the U.S. We bring together a multidisciplinary team of doctors, nurses and other health professionals experienced in treating children with inherited coagulation disorders and red blood cell disorders. We provide comprehensive care for infants, children, adolescents and young adults with:
 
  • Hemophilia and Von Willebrand disease
  • Platelet abnormalities, including idiopathic thrombocytopenic purpura (ITP), other thrombocytopenias and platelet dysfunction
  • Disorders of hemostasis and thrombosis
  • Red blood cell abnormalities, including sickle cell anemia and iron deficiency
  • Non-malignant hematologic disorders
  • Bone marrow and neutrophil disorders, including aplastic anemia, storage diseases and neutropenia
     
For patients with hemophilia and other inherited coagulation disorders, we provide consultations to hematologists and oncologists, pediatricians, pediatric surgeons, dentists and ob/gyns. Our areas of expertise include:
 
  • Inhibitors in hemophilia A and B
  • Risk factors for and prevention of inhibitor formation
  • Early diagnosis of inhibitors
  • Treatment of bleeding in patients with inhibitors
  • Prophylaxis to prevent bleeding and preserve joint health
  • Inhibitor eradication using Immune Tolerance Induction (ITI)
     
For patients with sickle cell disease and other red blood cell disorders, our emphasis is on preventing disease-related and treatment-related complications. We work to ensure that pain is adequately managed so that patients can maintain a good quality of life. We also work closely with the City of Hope Hematopoietic Cell Transplantation Program.
 
Given the hereditary nature of these conditions, we offer genetic testing, including carrier testing and counseling. We meet with the family after diagnosis to discuss the chances of having other children with a blood disorder, and we educate children in an age-appropriate manner.

Our program offers both medical treatment and psychosocial support to young patients and their family members. Our medical team collaborates to develop an effective, individualized treatment plan, while professionals in nursing; psychology; social work; physical, occupational and recreational therapy; and school re-integration provide individual attention and group activities for patients and their families.
 
The pediatric comprehensive care team for the hemophilia and the sickle cell programs includes:

Our physicians and scientists are leading research to find better treatments for patients with inherited blood disorders. For more information on our pediatric hematology research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 

Hemophilia & Sickle Cell

Hemophilia and Sickle Cell Program

The Hemophilia and Sickle Cell Program at City of Hope provides care to children, adolescents and young adults (AYA) with inherited coagulation disorders, such as hemophilia and red blood cell disorders like sickle cell anemia. We are a regional referral center for these disorders and provide support to hospitals and physicians locally, nationally and internationally.

Our hemophilia and sickle cell program has earned Center of Excellence designations from California Children’s Services, and we are one of approximately 145 federally funded comprehensive Hemophilia Treatment Centers (HTCs) in the U.S. We bring together a multidisciplinary team of doctors, nurses and other health professionals experienced in treating children with inherited coagulation disorders and red blood cell disorders. We provide comprehensive care for infants, children, adolescents and young adults with:
 
  • Hemophilia and Von Willebrand disease
  • Platelet abnormalities, including idiopathic thrombocytopenic purpura (ITP), other thrombocytopenias and platelet dysfunction
  • Disorders of hemostasis and thrombosis
  • Red blood cell abnormalities, including sickle cell anemia and iron deficiency
  • Non-malignant hematologic disorders
  • Bone marrow and neutrophil disorders, including aplastic anemia, storage diseases and neutropenia
     
For patients with hemophilia and other inherited coagulation disorders, we provide consultations to hematologists and oncologists, pediatricians, pediatric surgeons, dentists and ob/gyns. Our areas of expertise include:
 
  • Inhibitors in hemophilia A and B
  • Risk factors for and prevention of inhibitor formation
  • Early diagnosis of inhibitors
  • Treatment of bleeding in patients with inhibitors
  • Prophylaxis to prevent bleeding and preserve joint health
  • Inhibitor eradication using Immune Tolerance Induction (ITI)
     
For patients with sickle cell disease and other red blood cell disorders, our emphasis is on preventing disease-related and treatment-related complications. We work to ensure that pain is adequately managed so that patients can maintain a good quality of life. We also work closely with the City of Hope Hematopoietic Cell Transplantation Program.
 
Given the hereditary nature of these conditions, we offer genetic testing, including carrier testing and counseling. We meet with the family after diagnosis to discuss the chances of having other children with a blood disorder, and we educate children in an age-appropriate manner.

Our program offers both medical treatment and psychosocial support to young patients and their family members. Our medical team collaborates to develop an effective, individualized treatment plan, while professionals in nursing; psychology; social work; physical, occupational and recreational therapy; and school re-integration provide individual attention and group activities for patients and their families.
 
The pediatric comprehensive care team for the hemophilia and the sickle cell programs includes:

Our physicians and scientists are leading research to find better treatments for patients with inherited blood disorders. For more information on our pediatric hematology research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 
Patient Care Overview

City of Hope Locations

Faces of Cancer

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • Valentine’s Day is synonymous with dinner reservations, red roses, heart-shaped boxes of chocolates and — more often than not — unrealistically high expectations. Managing those expectations is great advice for all couples on Feb. 14 — and is especially important for couples confronting a cancer diagnosis. Focu...
  • With measles, what starts at a theme park in California definitely doesn’t stay at a theme park in California. Since the beginning of the current measles outbreak – traced to an initial exposure at Disneyland or Disney California Adventure during December – more than 100 people have been diagnosed with a diseas...
  • Even the most loving and secure relationship can be rattled by a life-threatening illness. When a woman is diagnosed with breast cancer, research shows one of the most important factors in helping her cope is having a supportive partner. But that partner can struggle with knowing what to say or how to best supp...
  • It’s been more than a century since Nobel Laureate Paul Ehrlich popularized the idea of a “magic bullet” targeting disease. Cancer researchers ever since have remained in hot pursuit of targeted therapies that home in on cancer cells while leaving normal cells unaffected. Linda Malkas, Ph.D., associate chair of...
  • Cancer patients face a daunting journey marked by challenges and uncertainties. For those undergoing bone marrow, or stem cell, transplantation, one complication poses a particular threat — chronic graft-versus-host disease (GVHD). Now, one researcher may have found a better way to control that threat. GVHD res...
  • Michele Dahlstein, a 50-year-old breast cancer survivor from Upland, California, celebrated her last day of chemotherapy on Dec. 30. She shares her story in her own words: I was diagnosed with breast cancer (invasive ductal carcinoma stage 2) on Aug. 11, 2014, after my yearly mammogram at City of Hope’s W...
  • The treatment of urologic cancers, including bladder cancer, is rapidly evolving. Here, urologic oncologic surgeon and kidney stone specialist Donald Hannoun, M.D., an assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope | Antelope Valley, explains the changes in hi...
  • A woman confronting metastatic breast cancer faces challenges that, at the outset, seem overwhelming. Research tells us these patients are especially vulnerable to anxiety, depression, hopelessness and other sources of distress. At the same time, they are asked to make complicated choices about their medical ca...
  • California health officials are opting to be safe rather than sorry when it comes to e-cigarettes. The increasingly popular devices are a public health threat, according to a California Department of Health report released Jan. 28. The department is seeking statewide regulation of e-cigarettes, saying they  emi...
  • “Not beyond us.” On World Cancer Day, researchers and caregivers around the globe are embracing this refrain. Specifically, the day calls for action to support healthier lifestyles, early cancer detection, quality of life and access to care. In a time of impressive scientific discovery and narrowing...
  • With more advanced cancer treatments and therapies saving lives every day, it’s safe to say cancer is “Not beyond us,” the official tagline for this year’s World Cancer Day. This year’s World Cancer Day observance takes place on Wednesday, Feb. 4, and focuses on cancer prevention, detection an...
  • Does our environment increase our risk of cancer? What about plastic bottles, radiation, chemicals, soy products …? Do they cause cancer? With so many cancer fears, rumors and downright urban legends circulating among our friends and colleagues, not to mention in the media and blogosphere, why not ask the...
  • With this week’s World Cancer Day challenging us to think about cancer on a global scale, we should also keep in mind that daily choices affect cancer risk on an individual scale. Simply put, lifestyle changes and everyday actions can reduce your cancer risk and perhaps prevent some cancers. According to ...
  • If you haven’t heard the term “precision medicine,” you will. If you don’t have an opinion about access to it, you will. On Friday, President Barack Obama unveiled details of the Precision Medicine Initiative, an effort intended to accelerate cancer research in a powerful way, giving doctors new knowledge and n...
  • The lack of a practical way to produce and store enough stem cells for larger-scale therapies and clinical trials is creating a bottleneck in stem cell research. A new grant to City of Hope from the California Institute for Regenerative Medicine (CIRM) will help solve that problem. The $899,728 grant, awarded T...